BIOMARIN PHARMACEUTICAL INC

CUSIP: 09061GAH4 Class: Convertible Debt

Candriam S.C.A.'s Holding History (CIK: 0001537014)

Note: Option positions (PUT/CALL) are excluded.

Q1 2024
Shares 250 Value ($000) $246 Avg Close — Range —
Q4 2023
Shares 250 Value ($000) $247 Avg Close — Range —
Q3 2023
Shares 850 Value ($000) $826 Avg Close — Range —
Q2 2023
Shares 850 Value ($000) $838 Avg Close — Range —
Q1 2023
Shares 250 Value ($000) $237 Avg Close — Range —
Q4 2022
Shares 250 Value ($000) $266 Avg Close — Range —
Q3 2022
Shares 450 Value ($000) $448 Avg Close — Range —
Q2 2022
Shares 800 Value ($000) $794 Avg Close — Range —
Q1 2022
Shares 800 Value ($000) $806 Avg Close — Range —
Q4 2021
Shares 800 Value ($000) $842 Avg Close — Range —
Q3 2021
Shares 800 Value ($000) $822 Avg Close — Range —
Q2 2021
Shares 800 Value ($000) $835 Avg Close — Range —
Q1 2021
Shares 800 Value ($000) $830 Avg Close — Range —
Q4 2020
Shares 800 Value ($000) $864 Avg Close — Range —
Q2 2020
Shares 2,600 Value ($000) $3,198 Avg Close — Range —
Q1 2020
Shares 3,000 Value ($000) $3,117 Avg Close — Range —
Q4 2019
Shares 3,000 Value ($000) $3,188 Avg Close — Range —
Q3 2019
Shares 3,000 Value ($000) $2,959 Avg Close — Range —
Q2 2019
Shares 3,000 Value ($000) $3,113 Avg Close — Range —
Q3 2018
Shares 200 Value ($000) $213 Avg Close — Range —
Q2 2018
Shares 200 Value ($000) $204 Avg Close — Range —
Q1 2018
Shares 400 Value ($000) $378 Avg Close — Range —
Q4 2017
Shares 300 Value ($000) $300 Avg Close — Range —
Q3 2017
Shares 200 Value ($000) $203 Avg Close — Range —